StroMed
AssetCell therapy
Stromal vascular fraction formulation combined with platelet-rich plasma for tissue regeneration.
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Not known
- Indications
- 1
- Trials
- 125
- Developers
- 1
Indications
1Osteoarthritis
Phase 2RECRUITINGNCT02844764clinicaltrials.gov7 Oct 2026
- Targets and what it contains1
- Owner and partners1
- Trials125
- Evidence for its targets1
- Aging relevance2
- Signals8
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources